Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith S Kaye

Showing results (131-140 of 421) with videos related to

Pageof 43
Sort By:
Archives of Internal Medicine|February 16, 2005
Risk factors for ineffective therapy in patients with bloodstream infectionJay R McDonald, N Deborah Friedman, Jason E Stout, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 12, 2023
Executive Summary: State-of-the-Art Review: State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative OrganismsArsheena Yassin, Mariya Huralska, Jason M Pogue, et al.
Contemporary Clinical Trials|May 7, 2025
Power considerations for the win ratio: A rank-based simulation approachLauren B Bonner, Jody D Ciolino, Keith S Kaye, et al.
JAMA|October 4, 2022
Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical TrialKeith S Kaye, Adam Belley, Philip Barth, et al.
Infectious Disease Clinics of North America|October 4, 2020
Agents of Last Resort: An Update on Polymyxin ResistanceQiwen Yang, Jason M Pogue, Zekun Li, et al.
Idcases|December 18, 2024
Disseminated histoplasmosis with oral involvement and co-infection with Pneumocystis in a patient with HIV: A case reportSusanne O Ajao, Nehar Damle, Michelle Zhao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2023
State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative OrganismsArsheena Yassin, Mariya Huralska, Jason M Pogue, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2018
Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic/pharmacodynamic modelKatie E Barber, Jason M Pogue, Henderson D Warnock, et al.
Infection Control and Hospital Epidemiology|March 11, 2005
The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital chargesSara E Cosgrove, Youlin Qi, Keith S Kaye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2014
Carbapenem-resistance in gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical CenterJason M Pogue, Anupama Neelakanta, Ryan P Mynatt, et al.
Pageof 43

Showing results (131-140 of 421) with videos related to

Sort By:
Pageof 43
Archives of Internal Medicine|February 16, 2005
Risk factors for ineffective therapy in patients with bloodstream infectionJay R McDonald, N Deborah Friedman, Jason E Stout, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 12, 2023
Executive Summary: State-of-the-Art Review: State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative OrganismsArsheena Yassin, Mariya Huralska, Jason M Pogue, et al.
Contemporary Clinical Trials|May 7, 2025
Power considerations for the win ratio: A rank-based simulation approachLauren B Bonner, Jody D Ciolino, Keith S Kaye, et al.
JAMA|October 4, 2022
Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical TrialKeith S Kaye, Adam Belley, Philip Barth, et al.
Infectious Disease Clinics of North America|October 4, 2020
Agents of Last Resort: An Update on Polymyxin ResistanceQiwen Yang, Jason M Pogue, Zekun Li, et al.
Idcases|December 18, 2024
Disseminated histoplasmosis with oral involvement and co-infection with Pneumocystis in a patient with HIV: A case reportSusanne O Ajao, Nehar Damle, Michelle Zhao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2023
State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative OrganismsArsheena Yassin, Mariya Huralska, Jason M Pogue, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2018
Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic/pharmacodynamic modelKatie E Barber, Jason M Pogue, Henderson D Warnock, et al.
Infection Control and Hospital Epidemiology|March 11, 2005
The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital chargesSara E Cosgrove, Youlin Qi, Keith S Kaye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2014
Carbapenem-resistance in gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical CenterJason M Pogue, Anupama Neelakanta, Ryan P Mynatt, et al.
Pageof 43